{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:58:12Z","timestamp":1793735892077,"version":"4.6.1"},"reference-count":29,"publisher":"Media Sphere Publishing House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>Cerebral amyloid angiopathy (CAA) is a progressive disease characterized by the deposition of \u03b2-amyloid in the walls of blood vessels in the brain, which leads to their damage and disruption of normal blood flow. Morphologically, CAA is characterized by both isolated lesions (microhemorrhages with the appearance of cortical superficial siderosis, lacunar infarctions) and widespread changes (hyperintensity of the deep and periventricular white matter, expansion of the perivascular spaces) of cortical and subcortical localization. CAA is considered a major cause of cognitive impairment and intracerebral microbleeds, especially in patients with Alzheimer\u2019s disease. The review presents modern ideas about the etiology, pathogenesis, clinical manifestations of CAA, and also outlines the provisions of the Boston principles of CAA, revised in 2022. Understanding the features of pathogenetic methods of CAA is crucial for adjusting the accuracy of diagnosis and developing treatment methods to preserve and prolong cognitive health.<\/jats:p>","DOI":"10.17116\/jnevro202412402185","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T12:07:15Z","timestamp":1710158835000},"page":"85","source":"Crossref","is-referenced-by-count":3,"title":["Cerebral amyloid angiopathy"],"prefix":"10.17116","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2597-981X","authenticated-orcid":false,"given":"E.A.","family":"Mkhitaryan","sequence":"first","affiliation":[{"name":"Russian Clinical and Research Center of Gerontology \u2014 Pirogov Russian National Research Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9935-3962","authenticated-orcid":false,"given":"V.V.","family":"Fateeva","sequence":"additional","affiliation":[{"name":"Russian Clinical and Research Center of Gerontology \u2014 Pirogov Russian National Research Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-3476","authenticated-orcid":false,"given":"P.R.","family":"Kamchatnov","sequence":"additional","affiliation":[{"name":"Pirogov Russian National Research Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202412402185-1","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2016150172"},{"key":"key-10.17116\/jnevro202412402185-2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1581993"},{"key":"key-10.17116\/jnevro202412402185-3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22516"},{"key":"key-10.17116\/jnevro202412402185-4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12366"},{"key":"key-10.17116\/jnevro202412402185-5","doi-asserted-by":"crossref","unstructured":"Makotrova TA, Levin OS, Arablinski\u012d AV. Cerebral amyloid angiopathy. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2014;114(6-2):87-93. (In Russ.)","DOI":"10.17116\/jnevro201411411232-36"},{"key":"key-10.17116\/jnevro202412402185-6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2010.01137.x"},{"key":"key-10.17116\/jnevro202412402185-7","doi-asserted-by":"crossref","unstructured":"Singh B, Lavezo J, Gavito-Higueroa J, et al. Updated Outlook of Cerebral Amyloid Angiopathy and Inflammatory Subtypes: Pathophysiology, Clinical Manifestations, Diagnosis and Management. J Alzheimers Dis Rep. 2022;6(1):627-639","DOI":"10.3233\/ADR-220055"},{"key":"key-10.17116\/jnevro202412402185-8","doi-asserted-by":"publisher","DOI":"10.1038\/nature13165"},{"key":"key-10.17116\/jnevro202412402185-9","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1866-3"},{"key":"key-10.17116\/jnevro202412402185-10","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01024-z"},{"key":"key-10.17116\/jnevro202412402185-11","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2015.17.1.17"},{"key":"key-10.17116\/jnevro202412402185-12","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.195511"},{"key":"key-10.17116\/jnevro202412402185-13","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2019.05.012"},{"key":"key-10.17116\/jnevro202412402185-14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-328792"},{"key":"key-10.17116\/jnevro202412402185-15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac178"},{"key":"key-10.17116\/jnevro202412402185-16","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.035836"},{"key":"key-10.17116\/jnevro202412402185-17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx047"},{"key":"key-10.17116\/jnevro202412402185-18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002175"},{"key":"key-10.17116\/jnevro202412402185-19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09558-9"},{"key":"key-10.17116\/jnevro202412402185-20","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00208-3"},{"key":"key-10.17116\/jnevro202412402185-21","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.563932"},{"key":"key-10.17116\/jnevro202412402185-22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10082"},{"key":"key-10.17116\/jnevro202412402185-23","unstructured":"Instructions for medical use of the drug Prospekta. State register of medicines. Available 12\/16\/2023. (In Russ.). https:\/\/grls.rosminzdrav.ru\/Grls_View_v2.aspx?routingGuid=13b7d400-1129-44a7-b96a-26dc2e9c2fe0"},{"key":"key-10.17116\/jnevro202412402185-24","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202112105133"},{"key":"key-10.17116\/jnevro202412402185-25","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202312307141"},{"key":"key-10.17116\/jnevro202412402185-26","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202212208188"},{"key":"key-10.17116\/jnevro202412402185-27","doi-asserted-by":"publisher","DOI":"10.18565\/therapy.2022.8.146-157"},{"key":"key-10.17116\/jnevro202412402185-28","unstructured":"Levin OS, Kovalchuk VV, Putilina MV, et al. Treatment of mild cognitive impairment of various origins in patients with chronic somatic diseases: results of a multicenter open prospective observational program (PARUS). Effective pharmacotherapy. Neurology and psychiatry. 2022;18(43):78-83. (In Russ.)"},{"key":"key-10.17116\/jnevro202412402185-29","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2023-1-65-70"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:01:05Z","timestamp":1745384465000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2024\/2\/1199772982024021085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3,11]]}},"alternative-id":["10.17116\/jnevro202412402185"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202412402185","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}